Alpha Tau Medical Income from Continuous Operations 2020-2024 | DRTS
Alpha Tau Medical income from continuous operations from 2020 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| Alpha Tau Medical Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-32 |
| 2023 | $-29 |
| 2022 | $-34 |
| 2021 | $-27 |
| 2020 | $-9 |
| 2019 | $-8 |
| Alpha Tau Medical Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-09-30 | |
| 2024-03-31 | $-8 |
| 2023-03-31 | $-8 |
| 2022-12-31 | $-3 |
| 2022-09-30 | $-3 |
| 2022-06-30 | $-2 |
| 2022-03-31 | $-26 |
| 2021-12-31 | $-4 |
| 2021-09-30 | $-5 |
| 2021-06-30 | $-7 |
| 2021-03-31 | $-12 |
| 2020-12-31 | |
| 2020-09-30 | $0 |
| 2019-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.183B | $0.000B |
| Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and potential commercialization of the Alpha DaRT for the treatment of solid tumors. Alpha Tau Medical Ltd., formerly known as Healthcare Capital Corp., is based in JERUSALEM. | |||